BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37169258)

  • 1. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.
    Poté N; Caruso S; Caderaro J; Cauchy F; Lagadec F; Couchy G; Raffenne J; Augustin J; Vernuccio F; Vilgrain V; Hercent A; Theou-Anton N; Zucman-Rossi J; Paradis V
    Mod Pathol; 2023 Sep; 36(9):100211. PubMed ID: 37169258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
    Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
    Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.
    Choi WT; Kakar S
    Adv Anat Pathol; 2018 Jul; 25(4):254-262. PubMed ID: 29649004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.
    Stueck AE; Qu Z; Huang MA; Campreciós G; Ferrell LD; Thung SN
    Semin Liver Dis; 2015 Nov; 35(4):444-9. PubMed ID: 26676820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
    Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
    Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
    Evason KJ; Grenert JP; Ferrell LD; Kakar S
    Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas.
    Larson BK; Guindi M
    Ann Diagn Pathol; 2021 Dec; 55():151833. PubMed ID: 34597957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in malignant transformation of hepatocellular adenoma.
    Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
    Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
    Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
    Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.
    Chopinet S; Cauchy F; Hobeika C; Beaufrère A; Poté N; Farges O; Dokmak S; Bouattour M; Ronot M; Vilgrain V; Paradis V; Soubrane O
    JHEP Rep; 2021 Aug; 3(4):100326. PubMed ID: 34368664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
    Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
    Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling.
    Joseph NM; Blank A; Shain AH; Gill RM; Umetsu SE; Shafizadeh N; Torbenson MS; Kakar S
    Hum Pathol; 2022 Apr; 122():60-71. PubMed ID: 35104461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
    Zheng J; Sadot E; Vigidal JA; Klimstra DS; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Ventura A
    PLoS One; 2018; 13(7):e0200776. PubMed ID: 30052636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of hepatocellular adenoma over a decade.
    Tokoro T; Kato Y; Sugioka A; Mizoguchi Y
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of hepatic adenomas.
    Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
    Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.